Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The standard Ozempic® pen holds 1.5 milliliters of solution containing four pre-set doses: 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Understanding how these doses work and why dose adjustment matters can help you optimize your GLP-1 therapy journey. PlexusDx offers compounded semaglutide injection as an affordable alternative with the same dose-escalation approach and transparent monthly pricing.
Understanding Ozempic® Pen Dose Structure
The Ozempic® pen is a pre-filled injection device manufactured by Novo Nordisk containing semaglutide solution. Each pen delivers exactly four distinct dose levels through a mechanical dial system. When you rotate the dial to your prescribed dose and press the injection button, the pen releases that specific amount of medication subcutaneously. The four standard doses (0.25 mg, 0.5 mg, 1 mg, and 2 mg) are engineered to last most patients through a full week or multiple weeks of treatment, depending on their dose protocol.
Patients typically begin with the lowest dose and increase it gradually over several weeks to minimize side effects and allow the body to adapt. This titration schedule reduces nausea and gastrointestinal discomfort while building tolerance to the medication's effects. Most people on Ozempic® start at 0.25 mg once weekly and progress upward based on their response and tolerance. The multi-dose pen design reduces the number of separate injections needed compared to single-dose vials, making treatment more convenient for patients managing their weight loss program.
How Semaglutide Dosing Works for Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by signaling fullness to your brain, slowing stomach emptying, and reducing hunger hormones. Clinical trials show that patients who reach higher doses (1 mg to 2.4 mg weekly) experience greater weight loss compared to those staying at lower doses. The FDA-approved starting dose of 0.25 mg is intentionally low to let your body adjust to the medication's effects before moving to higher amounts. Dose increases typically happen every four weeks until you reach your maintenance dose, which varies based on individual tolerance and weight loss goals.
Your healthcare provider monitors your response at each dose level and may recommend staying at a particular dose if side effects develop or if you're achieving satisfactory weight loss results. Some patients plateau at 0.5 mg or 1 mg and see excellent outcomes without needing higher doses. Others benefit from advancing to 1.5 mg or 2 mg for additional weight reduction. The personalized approach to dosing means your specific dose path depends on your body's unique response, baseline weight, metabolic factors, and tolerance to gastrointestinal effects.
PlexusDx Compounded Semaglutide vs. Brand-Name Options
PlexusDx sources compounded semaglutide injections from licensed 503A compounding pharmacies, offering the same active ingredient as brand-name Ozempic® at a more affordable starting price of $149 per month. Unlike some competitors, PlexusDx uses only certified 503A compounding facilities, which operate under strict FDA oversight and sterility standards. Compounded medications allow for more customized dosing flexibility because they're prepared specifically for each patient rather than manufactured in fixed pre-set amounts. This means your dose can increase as needed without your monthly price changing—following the PlexusDx principle that your dose may go up, but your price won't.
Many patients find compounded semaglutide a practical alternative when insurance denies coverage for brand-name Ozempic® or when out-of-pocket costs become prohibitive. PlexusDx serves all 50 states without requiring insurance approval, membership fees, or lengthy authorization delays. Patients pay one flat monthly rate regardless of whether they're at 0.25 mg or 2 mg, removing the financial barrier to appropriate dose titration. HSA and FSA accounts cover PlexusDx compounded semaglutide, adding another layer of cost accessibility for eligible patients.
Genetic Testing and Personalized Dose Optimization
PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that examines 14 biological pathways and 49 peptides influencing how your body responds to GLP-1 medications. Key genetic variants such as GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 affect your sensitivity to semaglutide and your likelihood of achieving optimal weight loss at specific dose levels. Understanding your genetic predispositions can help your healthcare provider predict which dose range may work best for your metabolism before you experience trial-and-error dosing adjustments. This precision approach reduces the time spent at suboptimal doses and accelerates your path to the most effective dose for your biology.
The Precision Peptide Genetic Test is available as a $99 add-on starting in your second month of treatment, making personalized pharmacology accessible alongside your medication therapy. Genetic insights may reveal whether you're a candidate for dose escalation beyond standard protocols or whether a lower maintenance dose will suffice based on your peptide-receptor sensitivity. Some patients discover they metabolize GLP-1 medications more efficiently, suggesting faster titration may be appropriate, while others benefit from more gradual increases due to genetic factors affecting appetite-signaling pathways. This data-driven approach transforms semaglutide from a one-size-fits-all treatment into a truly personalized weight loss strategy aligned with your unique genetic profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many injections do I get from one Ozempic® pen?
One Ozempic® pen contains four pre-measured doses (0.25 mg, 0.5 mg, 1 mg, and 2 mg), but you use only one dose per week. A single pen typically lasts 4 weeks at any given dose level, though some patients may extend it slightly depending on their exact dose. PlexusDx compounded semaglutide doesn't use a dial-pen system but delivers customized doses monthly at the same flat price.
Why does Ozempic® start at such a low dose?
Starting at 0.25 mg allows your gastrointestinal system and brain to adjust to semaglutide's effects gradually, significantly reducing nausea and other side effects. Clinical evidence shows that slow titration improves treatment adherence and patient satisfaction. Rapid dose escalation would cause severe nausea in most patients and increase the risk of dropping out of treatment before reaching an effective dose.
How much does PlexusDx semaglutide cost compared to Ozempic®?
PlexusDx compounded semaglutide injection starts at $149 per month, with no increase as your dose increases—your dose may go up, but your price won't. Most patients pay significantly less than brand-name Ozempic®, which can exceed $900 monthly even with insurance. PlexusDx serves all 50 states without requiring insurance approval or membership fees.
Can I stay on a lower dose of semaglutide and still lose weight?
Yes—many patients achieve meaningful weight loss at 0.5 mg or 1 mg and choose not to escalate further if they experience satisfactory results and good tolerance. Clinical trials show dose-dependent benefits, but individual responses vary widely. Your healthcare provider should help you decide whether advancing your dose is necessary based on your goals and side-effect profile.
How can genetic testing help me find my optimal semaglutide dose?
PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence your sensitivity to semaglutide and weight-loss response. Results predict whether you're likely to benefit from standard doses, require lower amounts due to high sensitivity, or might benefit from faster titration. At $99 (available from month two), this test can shorten your path to your ideal dose by reducing guesswork.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Should You Inject Zepbound for Optimal Results?
Is It Normal to Bruise After Ozempic Shot? What You Need to Know